Characterizing Neisseria spp. as novel respiratory pathobionts in bronchiectasis
M. Mac Aogáin (Singapore, Singapore), L. Liang (Shenzhen, China), T. Xu (Singapore, Singapore), T. Jaggi (Singapore, Singapore), L. Chan (Singapore, Singapore), H. Keir (Dundee, Scotland, United Kingdom), A. Dicker (Dundee, Scotland, United Kingdom), J. Qu (Shenzhen, China), Y. Liu (Shenzhen, China), H. Cheng (Singapore, Singapore), M. Koh (Singapore, Singapore), T. Ong (Singapore, Singapore), A. Hou (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), T. Low (Singapore, Singapore), B. Oliver (Sydney, NSW, Australia), N. Tan (Singapore, Singapore), M. Fang (Singapore, Singapore), J. Chalmers (Dundee, Scotland, United Kingdom), S. Chotirmall (Singapore, Singapore)
Source: Virtual Congress 2021 – Bronchiectasis
Session: Bronchiectasis
Session type: E-poster
Number: 2060
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Mac Aogáin (Singapore, Singapore), L. Liang (Shenzhen, China), T. Xu (Singapore, Singapore), T. Jaggi (Singapore, Singapore), L. Chan (Singapore, Singapore), H. Keir (Dundee, Scotland, United Kingdom), A. Dicker (Dundee, Scotland, United Kingdom), J. Qu (Shenzhen, China), Y. Liu (Shenzhen, China), H. Cheng (Singapore, Singapore), M. Koh (Singapore, Singapore), T. Ong (Singapore, Singapore), A. Hou (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), T. Low (Singapore, Singapore), B. Oliver (Sydney, NSW, Australia), N. Tan (Singapore, Singapore), M. Fang (Singapore, Singapore), J. Chalmers (Dundee, Scotland, United Kingdom), S. Chotirmall (Singapore, Singapore). Characterizing Neisseria spp. as novel respiratory pathobionts in bronchiectasis. 2060
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Chronic bronchial infection/colonisation: aetiology and mechanisms Source: Eur Respir Monogr 2013; 60: 34-45 Year: 2013
Significance of isolation of acinetobacter spp. from respiratory materials in patients with lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 303s Year: 2001
Distribution of respiratory manifestations during the Chlamidiae psittaci infections Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005
Atypical pathogens and respiratory tract infections Source: Eur Respir J 2004; 24: 171-182 Year: 2004
Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001
Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016
Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016
Asthma and Atypical Bacterial Infections: Chlamydia pneumonia, Mycoplasma pneumonia and Legionella pneumophila Source: Eur Respir J 2002; 20: Suppl. 38, 427s Year: 2002
Microbiology of non-CF bronchiectasis Source: Eur Respir Mon 2011; 52: 68-96 Year: 2011
Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007
Identification of viable and non-viable haemophilus influenzae using qPCR Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016
Antimicrobial peptides and airway bacterial colonization in bronchiectasis Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018
Causative bacteria in protracted bacterial bronchitis are biofilm forming species Source: International Congress 2018 – Orphan diseases in children Year: 2018
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways and exacerbations of bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
The impact of antibiotic resistance in the management of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131 Year: 2004
Molecular characterisation and clinical presentation of Mycoplasma pneumoniae lower respiratory tract infections in children Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017 Year: 2018
Macrolide-resistant mycoplasma pneumoniae in respiratory tract infection and its clinical relevance Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016